{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:30:41Z","timestamp":1778902241824,"version":"3.51.4"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T00:00:00Z","timestamp":1476144000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12890-016-0291-4","type":"journal-article","created":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T01:26:35Z","timestamp":1476149195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A systematic review of comparative studies of tiotropium Respimat\u00ae and tiotropium HandiHaler\u00ae in patients with chronic obstructive pulmonary disease: does inhaler choice matter?"],"prefix":"10.1186","volume":"16","author":[{"given":"Ronald","family":"Dahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,11]]},"reference":[{"key":"291_CR1","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.rmed.2013.04.005","volume":"107","author":"MJ Makela","year":"2013","unstructured":"Makela MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med. 2013;107:1481\u201390.","journal-title":"Respir Med"},{"key":"291_CR2","unstructured":"SPIRIVA\u00ae HandiHaler\u00ae (tiotropium bromide inhalation powder) capsules for respiratory inhalation [prescribing information]. Ridgefield, CT, USA: Boehringer Ingelheim Pharmaceuticals Inc. 2014."},{"key":"291_CR3","unstructured":"Spiriva 18 microgram inhalation powder, hard capsule. SPC. Boehringer Ingelheim Ltd. http:\/\/www.medicines.org.uk\/emc\/medicine\/10039\/SPC\/Spiriva+18microgram+inhalation+powder . Accessed 20 Aug 2015."},{"key":"291_CR4","unstructured":"SPIRIVA\u00ae Respimat\u00ae (tiotropium bromide) inhalation spray: for oral inhalation [prescribing information]. Ridgefield, CT, USA: Boehringer Ingelheim Pharmaceuticals, Inc. 2015."},{"key":"291_CR5","unstructured":"Spiriva (tiotropium) Respimat 2.5 micrograms, solution for inhalation. SPC. Boehringer Ingelheim Limited. https:\/\/www.medicines.org.uk\/emc\/medicine\/20134 . Accessed 20 Aug 2015."},{"key":"291_CR6","unstructured":"Product monograph SPIRIVA\u00ae Respimat\u00ae inhalation solution. Boehringer Ingelheim (Canada) Ltd. http:\/\/www.boehringer-ingelheim.ca\/content\/dam\/internet\/opu\/ca_EN\/documents\/humanhealth\/product_monograph\/SpirivaRespimatPMEN.pdf . Accessed 20 Aug 2015."},{"key":"291_CR7","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s40265-014-0307-4","volume":"74","author":"GM Keating","year":"2014","unstructured":"Keating GM. Tiotropium Respimat(\u00ae) Soft Mist inhaler: a review of its use in chronic obstructive pulmonary disease. Drugs. 2014;74:1801\u201316.","journal-title":"Drugs"},{"key":"291_CR8","unstructured":"Health Canada. PrSTRIVERDI RESPIMAT. 17-6-2014."},{"key":"291_CR9","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1177\/0091270006295788","volume":"47","author":"P Brand","year":"2007","unstructured":"Brand P, Meyer T, Weuthen T, Timmer W, Berkel E, Wallenstein G, et al. Lung deposition of radiolabeled tiotropium in healthy subjects and patients with chronic obstructive pulmonary disease. J Clin Pharmacol. 2007;47:1335\u201341.","journal-title":"J Clin Pharmacol"},{"key":"291_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1089\/089426801316970268","volume":"14","author":"S Chodosh","year":"2001","unstructured":"Chodosh S, Flanders JS, Kesten S, Serby CW, Hochrainer D, Witek TJJ. Effective delivery of particles with the HandiHaler dry powder inhalation system over a range of chronic obstructive pulmonary disease severity. J Aerosol Med. 2001;14:309\u201315.","journal-title":"J Aerosol Med"},{"key":"291_CR11","first-page":"145","volume":"4","author":"RN Dalby","year":"2011","unstructured":"Dalby RN, Eicher J, Zierenberg B. Development of Respimat\u00ae Soft Mist Inhaler and its clinical utility in respiratory disorders. Med Devices (Auckl). 2011;4:145\u201355.","journal-title":"Med Devices (Auckl)"},{"key":"291_CR12","first-page":"251","volume":"1","author":"P Anderson","year":"2006","unstructured":"Anderson P. Use of Respimat Soft Mist inhaler in COPD patients. Int J Chron Obstruct Pulmon Dis. 2006;1:251\u20139.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"291_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1089\/jam.2005.18.273","volume":"18","author":"D Hochrainer","year":"2005","unstructured":"Hochrainer D, Holz H, Kreher C, Scaffidi L, Spallek M, Wachtel H. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers. J Aerosol Med. 2005;18:273\u201382.","journal-title":"J Aerosol Med"},{"key":"291_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1089\/jam.2005.18.264","volume":"18","author":"G Pitcairn","year":"2005","unstructured":"Pitcairn G, Reader S, Pavia D, Newman S. Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler. J Aerosol Med. 2005;18:264\u201372.","journal-title":"J Aerosol Med"},{"issue":"Suppl 1","key":"291_CR15","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1089\/jam.1999.12.Suppl_1.S-19","volume":"12","author":"B Zierenberg","year":"1999","unstructured":"Zierenberg B. Optimizing the in vitro performance of Respimat. J Aerosol Med. 1999;12 Suppl 1:S19\u201324.","journal-title":"J Aerosol Med"},{"key":"291_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1586\/ers.11.89","volume":"6","author":"TG Capstick","year":"2012","unstructured":"Capstick TG, Clifton IJ. Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma. Expert Rev Respir Med. 2012;6:91\u2013101.","journal-title":"Expert Rev Respir Med"},{"key":"291_CR17","first-page":"337","volume":"37","author":"M Lippmann","year":"1980","unstructured":"Lippmann M, Yeates DB, Albert RE. Deposition, retention, and clearance of inhaled particles. Br J Ind Med. 1980;37:337\u201362.","journal-title":"Br J Ind Med"},{"key":"291_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2004.06.018","volume":"283","author":"R Dalby","year":"2004","unstructured":"Dalby R, Spallek M, Voshaar T. A review of the development of Respimat Soft Mist Inhaler. Int J Pharm. 2004;283:1\u20139.","journal-title":"Int J Pharm"},{"key":"291_CR19","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1021\/js950522q","volume":"85","author":"SP Newman","year":"1996","unstructured":"Newman SP, Steed KP, Reader SJ, Hooper G, Zierenberg B. Efficient delivery to the lungs of flunisolide aerosol from a new portable hand-held multidose nebulizer. J Pharm Sci. 1996;85:960\u20134.","journal-title":"J Pharm Sci"},{"issue":"11","key":"291_CR20","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.rmed.2015.09.013","volume":"109","author":"V Ninane","year":"2015","unstructured":"Ninane V, Vandevoorde J, Cataldo D, Derom E, Liistro G, Munghen E, et al. New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferences. Respir Med. 2015;109(11):1430\u20138.","journal-title":"Respir Med"},{"key":"291_CR21","unstructured":"Ciciliani A-M, Wachtel H, Langguth P. Comparing Respimat\u00ae Soft Mist\u2122 inhaler and DPI aerosol deposition by combined in vitro measurements and CFD simulations. Presented at: Respiratory Drug Delivery 2014; 4-8 May 2014; Fajardo, Puerto Rico."},{"key":"291_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2165\/11208620-000000000-00000","volume":"72","author":"GM Keating","year":"2012","unstructured":"Keating GM. Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease. Drugs. 2012;72:273\u2013300.","journal-title":"Drugs"},{"key":"291_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1378\/chest.1783312","volume":"144","author":"A Anzueto","year":"2013","unstructured":"Anzueto A, Wise R, Pledger G, Calverley P, Dusser D, Cotton D, et al. The Tiotropium Safety and Performance in Respimat (TIOSPIR) trial: bronchodilator efficacy in a spirometry substudy [abstract]. Chest. 2013;144:4. Meeting Abstracts:1027A.","journal-title":"Chest"},{"key":"291_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12931-015-0269-4","volume":"16","author":"A Anzueto","year":"2015","unstructured":"Anzueto A, Wise R, Calverley P, Dusser D, Tang W, Metzdorf N, et al. The Tiotropium Safety and Performance in Respimat\u00ae (TIOSPIR\u00ae) Trial: Spirometry Outcomes. Respir Res. 2015;16:107.","journal-title":"Respir Res"},{"issue":"Suppl 58","key":"291_CR25","first-page":"P3280","volume":"44","author":"I Bouloukaki","year":"2014","unstructured":"Bouloukaki I, Giannadaki K, Merigkis C, Michelakis S, Mauroudi E, Moniaki V, et al. Tiotropium Respimat versus HandiHaler to improve sleeping oxygen saturation and sleep quality in COPD [abstract]. Eur Respir J. 2014;44 Suppl 58:P3280.","journal-title":"Eur Respir J"},{"key":"291_CR26","first-page":"559","volume":"2","author":"D Caillaud","year":"2007","unstructured":"Caillaud D, Le Merre C, Martinat Y, Aguilaniu B, Pavia D. A dose-ranging study of tiotropium delivered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients. Int J Chron Obstruct Pulmon Dis. 2007;2:559\u201365.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"291_CR27","doi-asserted-by":"crossref","unstructured":"Calverley P, Anzueto A, Dahl R, Meuller A, Fowler A, Metzdorf N, et al. Tiotropium Safety and Performance In Respimat\u00ae (tiospir\u2122): safety and efficacy in patients with tiotropium Handihaler\u00ae use at baseline [abstract]. Thorax. 2014;69 Suppl 2:A192 (P262).","DOI":"10.1136\/thoraxjnl-2014-206260.390"},{"issue":"Suppl 58","key":"291_CR28","first-page":"925","volume":"44","author":"R Dahl","year":"2014","unstructured":"Dahl R, Schmidt H, K\u00f6nen-Bergmann M, Metzdorf N. Mixed treatment analysis comparing tiotropium HandiHaler\u00ae and Respimat\u00ae [abstract]. Eur Respir J. 2014;44 Suppl 58:925.","journal-title":"Eur Respir J"},{"issue":"12","key":"291_CR29","doi-asserted-by":"publisher","first-page":"e009015","DOI":"10.1136\/bmjopen-2015-009015","volume":"5","author":"R Dahl","year":"2015","unstructured":"Dahl R, Calverley P, Anzueto A. Safety and efficacy of tiotropium in patients switching from HandiHaler\u00ae to Respimat\u00ae in the TIOSPIR\u00ae trial. Submitted manuscript. BMJ Open. 2015;5(12):e009015.","journal-title":"BMJ Open"},{"key":"291_CR30","first-page":"239","volume":"10","author":"DM Halpin","year":"2015","unstructured":"Halpin DM, Dahl R, Hallmann C, Mueller A, Tashkin D. Tiotropium HandiHaler(\u00ae) and Respimat(\u00ae) in COPD: a pooled safety analysis. Int J Chron Obstruct Pulmon Dis. 2015;10:239\u201359.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"291_CR31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/jcph.215","volume":"54","author":"JM Hohlfeld","year":"2014","unstructured":"Hohlfeld JM, Sharma A, van Noord JA, Cornelissen PJ, Derom E, Towse L, et al. Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary disease. J Clin Pharmacol. 2014;54:405\u201314.","journal-title":"J Clin Pharmacol"},{"key":"291_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/ijcp.12596","volume":"69","author":"JM Hohlfeld","year":"2015","unstructured":"Hohlfeld JM, Furtwaengler A, Konen-Bergmann M, Wallenstein G, Walter B, Bateman ED. Cardiac safety of tiotropium in patients with COPD: a combined analysis of Holter-ECG data from four randomised clinical trials. Int J Clin Pract. 2015;69:72\u201380.","journal-title":"Int J Clin Pract"},{"key":"291_CR33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.rmed.2009.11.011","volume":"104","author":"M Ichinose","year":"2010","unstructured":"Ichinose M, Fujimoto T, Fukuchi Y. Tiotropium 5microg via Respimat and 18microg via HandiHaler; efficacy and safety in Japanese COPD patients. Respir Med. 2010;104:228\u201336.","journal-title":"Respir Med"},{"key":"291_CR34","doi-asserted-by":"crossref","unstructured":"Tashkin D, Jones P, Leonard T, Liu D, Metzdorf N, Zubeck V, Wise R. Tiotropium delivered via HandiHaler or Respimat: improvement in health-related quality of life in patients with chronic obstructive pulmonary disease [abstract]. Chest Journal. 2014;146(4_MeetingAbstracts):49A.","DOI":"10.1378\/chest.1994521"},{"issue":"Suppl 58","key":"291_CR35","first-page":"923","volume":"44","author":"D Tashkin","year":"2014","unstructured":"Tashkin D, Metzdorf N, Hallmann C, Konen-Bergmann M, Kupas K, Dalby R. Safety of tiotropium in renally impaired patients [abstract]. Eur Respir J. 2014;44 Suppl 58:923.","journal-title":"Eur Respir J"},{"key":"291_CR36","first-page":"A5770","volume":"191","author":"D Tashkin","year":"2015","unstructured":"Tashkin D, Kowey PR, Fowler A, Metzdorf N, Dewberry H, Mueller A, et al. Cardiac safety of tiotropium in patients with cardiac events: a retrospective, combined analysis of the UPLIFT\u00ae and TIOSPIR\u2122 trials [abstract]. Am J Respir Crit Care Med. 2015;191:A5770.","journal-title":"Am J Respir Crit Care Med"},{"key":"291_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.rmed.2008.10.002","volume":"103","author":"JA Noord van","year":"2009","unstructured":"van Noord JA, Cornelissen PJ, Aumann JL, Platz J, Mueller A, Fogarty C. The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients. Respir Med. 2009;103:22\u20139.","journal-title":"Respir Med"},{"issue":"Suppl 57","key":"291_CR38","first-page":"4632","volume":"42","author":"K Verhamme","year":"2013","unstructured":"Verhamme K, van Blijderveen N, Romio S, Stricker B, Brusselle G, Sturkenboom M. Chronic kidney disease as effect modifier in the association between the use of tiotropium Respimat and mortality [abstract]. Eur Respir J. 2013;42 Suppl 57:4632.","journal-title":"Eur Respir J"},{"key":"291_CR39","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1183\/09031936.00005813","volume":"42","author":"KM Verhamme","year":"2013","unstructured":"Verhamme KM, Afonso A, Romio S, Stricker BC, Brusselle GG, Sturkenboom MC. Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patients with COPD. Eur Respir J. 2013;42:606\u201315.","journal-title":"Eur Respir J"},{"key":"291_CR40","doi-asserted-by":"crossref","unstructured":"Wise R, Calverley P, Dahl R, Dusser D, Metzdorf N, Mueller A, et al. Tiotropium safety and performance in respimat\u00ae (tiospir\u2122): safety and efficacy in patients na\u00efve to treatment with anticholinergics [abstract]. Thorax. 2014;69 Suppl 2:A192 (P261).","DOI":"10.1136\/thoraxjnl-2014-206260.389"},{"key":"291_CR41","doi-asserted-by":"crossref","unstructured":"Wise R, Fowler A, Metzdorf N, Dewberry H, Mueller A, Kowey PR. Safety of tiotropium in patients with cardiac events in the TIOSPIR\u00ae trial. Presented at: European Respiratory Society International Congress; September 26-30, 2015; 26 September 2015.","DOI":"10.1183\/13993003.congress-2015.PA985"},{"key":"291_CR42","doi-asserted-by":"crossref","unstructured":"Wise R, Kowey PR, Austen G, Lawton A, Mueller A, Metzdorf N, et al. Investigator-reported versus adjudicated cause of death in the TIOSPIR\u00ae trial. Presented at: European Respiratory Society International Congress; September 26-30, 2015; 26 September 2015.","DOI":"10.1183\/13993003.congress-2015.PA1498"},{"key":"291_CR43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1465-9921-14-40","volume":"14","author":"RA Wise","year":"2013","unstructured":"Wise RA, Anzueto A, Calverley P, Dahl R, Dusser D, Pledger G, et al. The Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationale. Respir Res. 2013;14:40.","journal-title":"Respir Res"},{"issue":"2","key":"291_CR44","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s11325-015-1259-y","volume":"20","author":"I Bouloukaki","year":"2015","unstructured":"Bouloukaki I, Tzanakis N, Mermigkis C, Giannadaki K, Moniaki V, Mauroudi E, et al. Tiotropium Respimat Soft Mist Inhaler versus HandiHaler to improve sleeping oxygen saturation and sleep quality in COPD. Sleep Breath. 2015;20(2):605\u201312.","journal-title":"Sleep Breath"},{"key":"291_CR45","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1183\/09031936.00042113","volume":"42","author":"R Beasley","year":"2013","unstructured":"Beasley R. Tiotropium Respimat increases the risk of mortality: pro. Eur Respir J. 2013;42:584\u20139.","journal-title":"Eur Respir J"},{"key":"291_CR46","doi-asserted-by":"publisher","first-page":"d3215","DOI":"10.1136\/bmj.d3215","volume":"342","author":"S Singh","year":"2011","unstructured":"Singh S, Loke YK, Enright PL, Furberg CD. Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials. BMJ. 2011;342:d3215.","journal-title":"BMJ"},{"key":"291_CR47","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/08998280.2004.11927996","volume":"17","author":"MC Durham","year":"2004","unstructured":"Durham MC. Tiotropium (Spiriva): a once-daily inhaled anticholinergic medication for chronic obstructive pulmonary disease. Proc (Bayl Univ Med Cent). 2004;17:366\u201373.","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"291_CR48","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1056\/NEJMoa1303342","volume":"369","author":"RA Wise","year":"2013","unstructured":"Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, et al. Tiotropium Respimat inhaler and the risk of death in COPD. N Engl J Med. 2013;369:1491\u2013501.","journal-title":"N Engl J Med"},{"key":"291_CR49","first-page":"CD009285","volume":"7","author":"C Karner","year":"2014","unstructured":"Karner C, Chong J, Poole P. Tiotropium versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;7:CD009285.","journal-title":"Cochrane Database Syst Rev"},{"key":"291_CR50","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4104\/pcrj.2010.00067","volume":"19","author":"A Kaplan","year":"2010","unstructured":"Kaplan A. Effect of tiotropium on quality of life in COPD: a systematic review. Prim Care Respir J. 2010;19:315\u201325.","journal-title":"Prim Care Respir J"},{"key":"291_CR51","first-page":"A2924","volume":"185","author":"KMC Verhamme","year":"2012","unstructured":"Verhamme KMC, Afonso AS, Romio S, Stricker BC, Brusselle GG, Sturkenboom MC. Patient characteristics at first time use of tiotropium Handihaler vs tiotropium Respimat: is there a potential of channelling? [abstract]. Am J Respir Crit Care Med. 2012;185:A2924.","journal-title":"Am J Respir Crit Care Med"},{"key":"291_CR52","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/thoraxjnl-2014-205155","volume":"69","author":"NC Barnes","year":"2014","unstructured":"Barnes NC, Jones PW, Davis KJ. Safety of tiotropium through the Handihaler: why did meta-analyses and database studies appear to give a false alarm? Thorax. 2014;69:598\u20139.","journal-title":"Thorax"},{"key":"291_CR53","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.rmed.2013.09.013","volume":"107","author":"PN Dekhuijzen","year":"2013","unstructured":"Dekhuijzen PN, Vincken W, Virchow JC, Roche N, Agusti A, Lavorini F, et al. Prescription of inhalers in asthma and COPD: towards a rational, rapid and effective approach. Respir Med. 2013;107:1817\u201321.","journal-title":"Respir Med"},{"key":"291_CR54","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4104\/pcrj.2009.00062","volume":"19","author":"W Vincken","year":"2010","unstructured":"Vincken W, Dekhuijzen PR, Barnes P. ADMIT Group. The ADMIT series - Issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPD. Prim Care Respir J. 2010;19:10\u201320.","journal-title":"Prim Care Respir J"},{"key":"291_CR55","doi-asserted-by":"crossref","unstructured":"Borel JC, Pepin JL, Pison C, Vesin A, Gonzalez-Bermejo J, Court-Fortune I, et al. Long-term adherence with non-invasive ventilation improves prognosis in obese COPD patients. Respirology. 2014;19:857\u201365.","DOI":"10.1111\/resp.12327"},{"key":"291_CR56","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2147\/COPD.S3391","volume":"4","author":"R Hodder","year":"2009","unstructured":"Hodder R, Price D. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhaler. Int J Chron Obstruct Pulmon Dis. 2009;4:381\u201390.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"291_CR57","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.rmed.2011.01.005","volume":"105","author":"AS Melani","year":"2011","unstructured":"Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105:930\u20138.","journal-title":"Respir Med"},{"key":"291_CR58","first-page":"A639","volume":"175","author":"F Freytag","year":"2007","unstructured":"Freytag F, Rau-Berger H, Glaab T, Wolf K. Respimat\u00ae Soft Mist\u2122 inhaler preferred to Diskus by patients with COPD and\/or asthma [abstract]. Am J Respir Crit Care Med. 2007;175:A639.","journal-title":"Am J Respir Crit Care Med"},{"key":"291_CR59","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2147\/COPD.S3452","volume":"4","author":"R Hodder","year":"2009","unstructured":"Hodder R, Reese PR, Slaton T. Asthma patients prefer Respimat Soft Mist Inhaler to Turbuhaler. Int J Chron Obstruct Pulmon Dis. 2009;4:225\u201332.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"291_CR60","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2165\/00151829-200504010-00006","volume":"4","author":"W Schurmann","year":"2005","unstructured":"Schurmann W, Schmidtmann S, Moroni P, Massey D, Qidan M. Respimat Soft Mist inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfaction. Treat Respir Med. 2005;4:53\u201361.","journal-title":"Treat Respir Med"},{"key":"291_CR61","unstructured":"ADESPI Adherence to Spiriva\u00ae in Patients With COPD (Chronic Obstructive Pulmonary Disease), Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical Practice. NCT01388166. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01388166 . Accessed 20 Aug 2015."},{"key":"291_CR62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/jamp.2011.0941","volume":"26","author":"Y Asakura","year":"2013","unstructured":"Asakura Y, Nishimura N, Maezawa K, Terajima T, Kizu J, Chohnabayashi N. Effect of switching tiotropium HandiHaler\u00ae to Respimat\u00ae Soft Mist\u2122 Inhaler in patients with COPD: the difference of adverse events and usability between inhaler devices. J Aerosol Med Pulm Drug Deliv. 2013;26:41\u20135.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"291_CR63","first-page":"69","volume":"10","author":"S Hanada","year":"2015","unstructured":"Hanada S, Wada S, Ohno T, Sawaguchi H, Muraki M, Tohda Y. Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch. Int J Chron Obstruct Pulmon Dis. 2015;10:69\u201377.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"291_CR64","first-page":"A1604","volume":"189","author":"N Nishimura","year":"2014","unstructured":"Nishimura N, Asakura Y, Junta T, Suda R, Yamao S, Tomishima Y, et al. Therapeutic effect of switching tiotropium HandiHaler to Respimat Soft Mist\u2122 inhaler in the patients with COPD: the difference of adverse events and adherence to manipulations between inhaler devices [abstract]. Am J Respir Crit Care Med. 2014;189:A1604.","journal-title":"Am J Respir Crit Care Med"},{"key":"291_CR65","doi-asserted-by":"crossref","first-page":"A6004","DOI":"10.1164\/rccm.201306-1039OC","volume":"189","author":"S Suzuki","year":"2014","unstructured":"Suzuki S, Sagara H, Tanaka A, Yamaguchi M, Ohta S, Homma T, et al. Effect of switching administration of tiotropium, HandiHaler to Respimat Soft Mist Inhaler in COPD patients: focus on physical characteristics and background of COPD patients before changing inhaler devices. Am J Respir Crit Care Med. 2014;189:A6004.","journal-title":"Am J Respir Crit Care Med"},{"key":"291_CR66","doi-asserted-by":"publisher","first-page":"e006619","DOI":"10.1136\/bmjopen-2014-006619","volume":"5","author":"F Trotta","year":"2015","unstructured":"Trotta F, Da Cas R, Rajevic M, Rossi M, Traversa G. Risk factors influencing the prescription of tiotropium Respimat formulation: a population-based cohort study. BMJ Open. 2015;5:e006619.","journal-title":"BMJ Open"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-016-0291-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-016-0291-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-016-0291-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T11:36:48Z","timestamp":1692531408000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-016-0291-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,11]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["291"],"URL":"https:\/\/doi.org\/10.1186\/s12890-016-0291-4","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,11]]},"article-number":"135"}}